We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

152 hedge funds and large institutions have $1.57B invested in Acorda Therapeutics in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 57 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $2.9M | Put options by funds: $1.97M

34% more capital invested

Capital invested by funds: $1.17B → $1.57B (+$395M)

7% less funds holding

Funds holding: 163 → 152 (-11)

21% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 57

28% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 32

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
152
Holders Change
-11
Holders Change %
-6.75%
% of All Funds
4.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
23
Increased
45
Reduced
57
Closed
32
Calls
$2.9M
Puts
$1.97M
Net Calls
+$926K
Net Calls Change
+$691K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$33.7M
2
PHS
PFM Health Sciences
California
+$24.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.2M
4
PC
PointState Capital
New York
+$16.8M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
TSW
Thompson Siegel & Walmsley
Virginia
-$15.6M
2
AG
Artal Group
Luxembourg
-$11.8M
3
HM
HealthCor Management
New York
-$11.7M
4
Goldman Sachs
Goldman Sachs
New York
-$11.4M
5
BIT
BlackRock Institutional Trust
California
-$10.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
51
Charles Schwab
California
$4.16M +$101K +25 +3%
PAMU
52
Pictet Asset Management (UK)
United Kingdom
$4.03M +$194K +48 +6%
RCAMU
53
Rothschild & Co Asset Management US
Connecticut
$3.97M -$5.86M -1,450 -62%
Deutsche Bank
54
Deutsche Bank
Germany
$3.81M -$251K -62 -7%
1CM
55
1492 Capital Management
Wisconsin
$3.78M +$3.36M +831 New
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$3.48M +$526K +130 +20%
SONJCPFA
57
State of New Jersey Common Pension Fund A
New Jersey
$3.41M – – –
MSA
58
Mason Street Advisors
Wisconsin
$3.22M -$52.6K -13 -2%
AllianceBernstein
59
AllianceBernstein
Tennessee
$3.17M -$247K -61 -8%
Public Sector Pension Investment Board (PSP Investments)
60
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.16M -$582K -144 -17%
BlackRock
61
BlackRock
New York
$3.11M +$190K +47 +7%
Two Sigma Investments
62
Two Sigma Investments
New York
$2.9M +$1.14M +281 +79%
ProShare Advisors
63
ProShare Advisors
Maryland
$2.84M +$1.76M +435 +229%
ERSOT
64
Employees Retirement System of Texas
Texas
$2.81M +$1.21M +300 +95%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.8M +$12.1K +3 +0.5%
Royal London Asset Management
66
Royal London Asset Management
United Kingdom
$2.66M +$2.92M +722 New
Morgan Stanley
67
Morgan Stanley
New York
$2.63M -$8.1M -2,004 -78%
SIM
68
Spark Investment Management
New York
$2.62M -$420K -104 -15%
AQR Capital Management
69
AQR Capital Management
Connecticut
$2.15M +$303K +75 +19%
DCM
70
Dupont Capital Management
Delaware
$2.14M – – –
MOACM
71
Mutual of America Capital Management
New York
$2.02M – – –
U
72
UBS
Switzerland
$1.96M -$198K -49 -10%
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
$1.92M +$368K +91 +27%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.89M -$8.09K -2 -0.5%
NFA
75
Nationwide Fund Advisors
Ohio
$1.83M – – –
1 2
3
4 5

ACOR Hedge Fund Activity: Q1 2014 in Review

152 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2014, worth a combined $1.57B — up 34% from $1.17B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ACOR and 23 opened new positions — a net loss of 9 holders — while 57 trimmed existing stakes and 45 added.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $33.7M. The largest seller was Thompson Siegel & Walmsley, cutting an estimated $15.6M.

  • 152 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2014, down from 163 in Q4 2013.
  • Funds reported $1.57B of Acorda Therapeutics stock for Q1 2014, up 34% quarter-over-quarter.
  • 23 funds opened new Acorda Therapeutics positions in Q1 2014 and 32 closed out, a net change of -9 holders.
  • The largest Acorda Therapeutics buyer in Q1 2014 was Baker Bros. Advisors, an estimated $33.7M added.
  • The largest Acorda Therapeutics seller in Q1 2014 was Thompson Siegel & Walmsley, an estimated $15.6M sold.

Based on aggregated 13F filings for Q1 2014.